Home › Diabetic Foot › NCT07046767
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations
A Multicenter Hybrid Platform Trial Comparing the Effects of a Prospective Cohort Treated With a Tri- Layer Amnion Graft or a Single Layer Amnion Graft to a Coarsened Exact Matched Retrospective Control Cohort of Patients With Hard-to-heal DFUs and VLUs
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Male or female 18 years of age and older 2. 2\. Subjects having a non-healing venous leg ulcer or diabetic foot ulcer of \>4 weeks duration and visible signs of healing objectively, less than 50% reduction in wound size in the last 4 weeks 3. Subjects' wound size is minimum of 2 cm2 and maximum of 25cm2 4. If the subject has more than one eligible wound the largest wound will be selected (the index wound) 5. Subject is able and willing to follow the protocol requirements 6. Subject has signed informed consent Exclusion Criteria: 1. Inability to adhere to the study protocol or study visit schedule 2. Pregnancy 3. Child-bearing potential without appropriate contraception 4. Lactation 5. Treatment of the wound with engineered tissue or other scaffold materials within 30 days preceding the first treatment visit. 6. Visible signs of improvement in the four weeks before randomisation (defined objectively as a 50% reduction in surface area in the four weeks before enrolment) 7. The subject has other concurrent conditions that in the opinion of the investigator may compromise subject safety 8. Known contraindications to the use of amniotic tissue grafts 9. The index ulcer shows clinical signs and symptoms of wound infection needing treatment with local or systemic antimicrobials or antibiotics
About the study
CAMP RWE Trial: A Multicenter hybrid platform trial comparing the effects of a prospective cohort treated with a tri-layer amnion graft or a single layer amnion graft to a coarsened exact matched retrospective control cohort of patients with hard-to-heal DFUs and VLUs
What is being tested
- IP1: BioLab Membrane Wrap Lite IP2: BioLab Tri-Membrane Wrap (other)
- IP2: BioLab Tri-Membrane Wrap (other)
Sponsor: Capsicure, LLC · Participants: 165 · Started: Oct 1, 2025
Contact the study team
- Marissa Docter, RN, BSN, MD · Phone: 512-571-2966
Official record on ClinicalTrials.gov — NCT07046767
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.